Browse Category

NYSE:WDS News 11 January 2026 - 26 January 2026

Woodside Energy share price: ASX shut for Australia Day, oil holds gains as WDS heads into Q4 update

Woodside Energy share price: ASX shut for Australia Day, oil holds gains as WDS heads into Q4 update

Sydney, Jan 26, 2026, 17:33 AEDT — Market closed. Woodside Energy Group Ltd (WDS.AX) shares ended Friday at A$24.08, slipping 0.5%. Australia’s market was closed Monday for the Australia Day public holiday. (Investing) The break is significant as it squeezes the week for local traders aiming to gear up before Woodside’s upcoming earnings. Settlement and reporting timetables are also shuffled…
Woodside Energy stock (ASX:WDS) ends higher as oil jumps — what to watch before Monday

Woodside Energy stock (ASX:WDS) ends higher as oil jumps — what to watch before Monday

Sydney, Jan 11, 2026, 16:55 AEDT — Market closed. Woodside Energy Group Ltd (WDS.AX) shares finished Friday up 2.8% at A$23.59, from a prior close of A$22.95. With the Australian market shut on Sunday, traders head into the new week watching crude first, company news second. (Investing) Why it matters now is simple: Woodside is priced like an oil-and-gas name,…

Stock Market Today

  • USA Rare Earth Gains on $1.6bn U.S. Investment; Ryanair Profits Fall; Revolution Medicines Shares Drop
    January 26, 2026, 5:22 AM EST. USA Rare Earth shares jumped 19% pre-market after reports of a $1.6 billion U.S. government investment for a 10% stake, marking the largest in the sector. Cancer drug developer Revolution Medicines fell over 19% as Merck ended talks to acquire it amid price disagreements. In Europe, Ryanair's shares dipped nearly 2% following a 22% decline in quarterly profits, impacted by an €85 million fine, though the company plans to appeal. Despite the charge, Ryanair posted a 9% revenue rise and expects steady profit growth. London's FTSE 100 miner Fresnillo climbed 4% early Monday, benefiting from rising precious metal prices. These moves highlight shifts in government-backed investments, biotech deal uncertainties, and European airline profitability amidst regulatory challenges.
Go toTop